ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS Trademark

Trademark Overview


On Monday, August 25, 2025, a trademark application was filed for ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS trademark a serial number of 99355960. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, August 25, 2025. This trademark is owned by Fosun Pharma USA Inc.. The ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
archimmune architecting immuno-oncology solutions

General Information


Serial Number99355960
Word MarkARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS
Filing DateMonday, August 25, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, August 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of purple circle icon with three intersecting curved white lines. The intersecting white lines comprise five sections of the circle in various sizes where the curve of the circle forms the outer edge of each shape; the top left of the circle is a gradient purple shape, the top right is a purple shape, the middle is a green triangular shape, the bottom left is a small purple triangular shape, and the bottom right is a gradient purple and orange shape. Below the circle icon is the word ARCHIMMUNE where the letters ARCH are gray capital letters in light font and the letters IMMUNE are purple capital letters in heavy font, all of which is above the words ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS in gray capitalized text. Areas in white not claimed herein are for background only and are not claimed as part of the mark.
Indication of Colors claimedThe color(s) purple, green, orange, gray and white is/are claimed as a feature of the mark.
NOT AVAILABLE"SOLUTIONS"
Goods and ServicesConsulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 25, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFosun Pharma USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Monday, August 25, 2025NEW APPLICATION ENTERED
Monday, August 25, 2025APPLICATION FILING RECEIPT MAILED